Lysine adsorption on the silanized SiO2-surface for immobilization of the estrogen receptor hERα

被引:3
|
作者
Cherkouk, C. [1 ]
Rebohle, L. [1 ]
Skorupa, W. [1 ]
机构
[1] Forschungszentrum Dresden Rossendorf, Inst Ion Beam Phys & Mat Res, D-01314 Dresden, Germany
关键词
Lysine; Adsorption; SiO2; Immobilization; pH value; Silanization; XPS; FTIR; AMINO-ACIDS; SURFACES; SILICA; FILMS; XPS; SPECTROSCOPY; BINDING;
D O I
10.1016/j.apsusc.2010.12.101
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
We investigated the adsorption of the L-lysine (200 mmol) molecule to a silanized SiO2 surface as a function of the pH value. The SSC (Spraying Spin Coating) method [Cherkouk et al., J. Colloid Interf. Sci. 337 (2009) 375-380] was applied to functionalize the SiO2 surface by using the (3-aminopropyl)trimethoxysilane (APMS) as coupling agent with a NH2 functional group. We adsorbed lysine molecules to the silane film for pH-values of 2.5, 7.5, 8.7, 9.5 and 13, which correspond to the di-cationic, cationic, zwitterinonic (pH 8.7 and 9.5) and the anionic charge state of lysine, respectively. The infrared spectroscopy is not suitable to investigate the system because the NH3+ signal at 1600 cm(-1) originating from the silane film overlaps with the infrared signal of the deprotonated carboxyl group of the lysine molecule. X-ray photoelectron spectroscopy (XPS) was used to measure the binding energies C 1s and N 1s as function of the pH value. This pH change affects the charge state which was fitted in the XPS spectra to obtain the optimal adsorption conditions at pH 7.5 of the lysine to the functionalized SiO2 surface. (c) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:4831 / 4835
页数:5
相关论文
共 50 条
  • [41] Breast Cancer Biomarkers Challenges in Routine Estrogen Receptor, Progesterone Receptor, and HER2/neu Evaluation
    Jorns, Julie M.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2019, 143 (12) : 1444 - 1449
  • [42] Histologic and immunophenotypic features of estrogen receptor, progesterone receptor, Her2/neu negative breast carcinomas
    Baruch, AC
    Sneige, N
    Cristofanilli, M
    Resetkova, E
    LABORATORY INVESTIGATION, 2006, 86 : 21A - 21A
  • [43] Estrogen Receptor, Progesterone Receptor, and HER2 Status Predict Lymphovascular Invasion and Lymph Node Involvement
    Stacy Ugras
    Michelle Stempel
    Sujata Patil
    Monica Morrow
    Annals of Surgical Oncology, 2014, 21 : 3780 - 3786
  • [44] Alteration of estrogen receptor, progesterone receptor, and HER-2 expression in breast cancer after neoadjuvant chemotherapy
    Lee, Jong Won
    Han, Wonshik
    Ko, Eunyoung
    Cho, Jihyoung
    Jung, So-Youn
    Kim, Eun-Kyu
    Keam, Bhumsuk
    Im, Seock-Ah
    Lee, Ho-Chang
    Park, In Ae
    Oh, Seung Keun
    Youn, Yeo-Kyu
    Kim, Sung-Won
    Hwang, Ki-Tae
    Noh, Dong-Young
    JOURNAL OF BREAST CANCER, 2007, 10 (03) : 206 - 210
  • [45] Estrogen Receptor, Progesterone Receptor, and HER2 Status Predict Lymphovascular Invasion and Lymph Node Involvement
    Ugras, Stacy
    Stempel, Michelle
    Patil, Sujata
    Morrow, Monica
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (12) : 3780 - 3786
  • [46] Validation of Linear Range HER2/Estrogen Receptor/Progesterone Receptor IHControls for Daily Quality Assurance
    Sompuram, Seshi R.
    Vani, Kodela
    Ryan, Lori
    Johnson, Corissa
    Szabolcs, Matthias
    Peruyero, Leonore
    Balaton, Andre
    Pierrot, Sandrine
    Joseph, Lija
    Pilichowska, Monika
    Naber, Stephen
    Goldsmith, Jeffrey
    Green, Samantha
    Bogen, Steve A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 159 (03) : 274 - 282
  • [47] Prognostic significance of estrogen receptor in hormone receptor-positive and HER2-positive breast cancer
    Hikichi, M.
    Ushimado, K.
    Ri, Y.
    Kobayashi, N.
    Utsumi, T.
    BREAST, 2017, 32 : S94 - S95
  • [48] Histologic and immunophenotypic features of estrogen receptor, progesterone receptor, Her2/neu negative breast carcinomas
    Baruch, AC
    Sneige, N
    Cristofanilli, M
    Resetkova, E
    MODERN PATHOLOGY, 2006, 19 : 21A - 21A
  • [49] Association between HER2 oncoprotein and hormonal receptors (estrogen receptor and progesterone receptor) on breast cancer
    Fulkiadli, F.
    Khambri, D.
    Harahap, W.
    ANNALS OF ONCOLOGY, 2017, 28
  • [50] Clinical considerations for estrogen receptor-negative/ progesterone receptor-positive/HER2-negative (ER-PR+HER2-) breast cancer
    Rala de Paula, Bruno Henrique
    Crocamo, Susanne
    Bines, Jose
    TRANSLATIONAL BREAST CANCER RESEARCH, 2023, 4